BIO Welcomes President Obama’s Council on Jobs and Competitiveness Meeting at Leading Biotechnology Company During Visit t

Biotech Sector Drives Job Creation and Innovation

WASHINGTON--(BUSINESS WIRE)-- Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on President Obama’s trip to North Carolina to meet with members of the President’s Council on Jobs and Competitiveness:

“BIO is honored that the President’s Council on Jobs and Competitiveness has included our member company Biogen Idec in its visit to North Carolina to discuss job creation and economic growth. The biotechnology industry has been an engine for economic development and job creation across the country, especially in North Carolina, which is a national leader in biosciences.

“Our sector employs over 50,000 North Carolinians directly and supports a total of 250,000 jobs in the state. These are high wage, high quality, high innovation jobs at companies working to improve the health and the quality of life for patients around the globe.

“Last fall, the President’s Therapeutic Discovery Project (TDP) awarded grants and tax credits to 99 small North Carolina bioscience companies to help fund cutting edge research for the development of new cutting-edge medical treatments and cures and to reduce health care costs. The $36 million investment helped North Carolina companies retain and hire employees to support groundbreaking research.

“It is fitting that President Obama selected a leading biotechnology company like Biogen Idec as a venue for a visit by members of the President’s Council on Jobs and Competitiveness. As the President has said, ‘The first step in winning the future is encouraging American innovation.’ Our sector continues to be one of the most innovative industries in the U.S. and remains a world leader in an increasingly competitive global marketplace. BIO thanks President Obama and the members of the President’s Council on Jobs and Competitiveness for recognizing biotech’s contribution and commitment to job creation and economic growth.”

Upcoming BIO Events

Partnering for Global Health Forum 2011
June 27, 2011
Washington, DC

BIO International Convention
June 27-30, 2011
Washington, DC

2011 BIO Human Resources Conference
June 26-28, 2011
Washington, DC

The Business Forum at the BIO International Convention
June 28-30, 2011
Washington, DC

BIO India International Partnering Conference
September 21-22, 2011
Hyderabad, India

BIO China International Conference
October 12-13, 2011
Shanghai, China

About BIO

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.

For more information:
Visit http://www.bio.org
Follow us on Twitter @IAmBiotech
Join us on LinkedIn/MyBio
Become a fan at facebook.com/IAmBiotech



CONTACT:

Biotechnology Industry Organization (BIO)
Jeff Joseph, 202-962-9230
[email protected]

KEYWORDS:   United States  North America  District of Columbia  North Carolina

INDUSTRY KEYWORDS:   Health  Biotechnology  Public Policy/Government  Healthcare Reform  Congressional News/Views  Public Policy  State/Local  White House/Federal Government  Research  Science  General Health

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.